O1 Tumour heterogeneity: what does it mean?

Dow-Mu Koh

O2 Skeletal sequelae in adult survivors of childhood cancer

Sue Creviston Kaste

O3 Locoregional effects of breast cancer treatment

Sarah J Vinnicombe

O4 Imaging of cancer therapy-induced CNS toxicity

Giovanni Morana, Andrea Rossi

O5 Screening for lung cancer

Christian J. Herold

O6Risk stratification of lung nodules

Theresa C. McLoud

O7 PET imaging of pulmonary nodules

Kirk A Frey

O8 Transarterial tumour therapy

Bernhard Gebauer

O9 Interventional radiology in paediatric oncology

Derek Roebuck

O10 Image guided prostate interventions

Jurgen J. Fütterer

O11 Imaging cancer predisposition syndromes

Alexander J. Towbin

O12Chest and chest wall masses

Thierry AG Huisman

O13 Abdominal masses: good or bad?

Anne MJB Smets

O14 Hepatobiliary MR contrast: enhanced liver MRI for HCC diagnosis and management

Giovanni Morana

O15 Role of US elastography and multimodality fusion for managing patients with chronic liver disease and HCC

Jeong Min Lee

O16 Opportunities and challenges in imaging metastatic disease

Hersh Chandarana

O17 Diagnosis, treatment monitoring, and follow-up of lymphoma

Marius E. Mayerhoefer, Markus Raderer, Alexander Haug

O18 Managing high-risk and advanced prostate cancer

Matthias Eiber

O19 Immunotherapy: imaging challenges

Bernhard Gebauer

O20 RECIST and RECIST 1.1

Andrea Rockall

O21 Challenges of RECIST in oncology imaging basics for the trainee and novice

Aslam Sohaib

O22 Lymphoma: PET for interim and end of treatment response assessment: a users’ guide to the Deauville Score

Victoria S Warbey

O23 Available resources

Hebert Alberto Vargas

O24 ICIS e-portal and the online learning community

Dow-Mu Koh

O25 Benign lesions that mimic pancreatic cancer

Jay P Heiken

O26 Staging and reporting pancreatic malignancies

Isaac R Francis, Mahmoud, M Al-Hawary, Ravi K Kaza

O27 Intraductal papillary mucinous neoplasm

Giovanni Morana

O28 Cystic pancreatic tumours

Mirko D’Onofrio

O29 Diffusion-weighted imaging of head and neck tumours

Harriet C. Thoeny

O30 Radiation injury in the head and neck

Ann D King

O31 PET/MR of paediatric brain tumours

Giovanni Morana, Arnoldo Piccardo, Maria Luisa Garrè, Andrea Rossi

O32 Structured reporting and beyond

Hebert Alberto Vargas

O33 Massachusetts General Hospital experience with structured reporting

Theresa C. McLoud

O34 The oncologist’s perspective: what the oncologist needs to know

Nick Reed

O35 Towards the cure of all children with cancer: global initiatives in pediatric oncology

Carlos Rodriguez-Galindo

O36 Multiparametric imaging of renal cancers

Hersh Chandarana

O37 Linking imaging features of renal disease and their impact on management strategies

Hebert Alberto Vargas

O38 Adrenals, retroperitoneum and peritoneum

Isaac R Francis, Ashish P Wasnik

O39 Lung and pleura

Stefan Diederich

O40 Advances in MRI

Jurgen J. Fütterer

O41 Advances in molecular imaging

Wim J.G. Oyen

O42 Incorporating advanced imaging, impact on treatment selection and patient outcome

Cheng Lee Chaw, Nicholas van As

S1 Combining ADC-histogram features improves performance of MR diffusion-weighted imaging for Lymph node characterisation in cervical cancer

Igor Vieira, Frederik De Keyzer, Elleke Dresen, Sileny Han, Ignace Vergote, Philippe Moerman, Frederic Amant, Michel Koole, Vincent Vandecaveye

S2 Whole-body diffusion-weighted MRI for surgical planning in patients with colorectal cancer and peritoneal metastases

R Dresen, S De Vuysere, F De Keyzer, E Van Cutsem, A D’Hoore, A Wolthuis, V Vandecaveye

S3 Role of apparent diffusion coefficient (ADC) diffusion-weighted MRI for predicting extra capsular extension of prostate cancer.

P. Pricolo (paola.pricolo@ieo.it), S. Alessi, P. Summers, E. Tagliabue, G. Petralia

S4 Generating evidence for clinical benefit of PET/CT – are management studies sufficient as surrogate for patient outcome?

C. Pfannenberg, B. Gückel, SC Schüle, AC Müller, S. Kaufmann, N. Schwenzer, M. Reimold,C. la Fougere, K. Nikolaou, P. Martus

S5 Heterogeneity of treatment response in skeletal metastases from breast cancer with 18F-fluoride and 18F-FDG PET

GJ Cook, GK Azad, BP Taylor, M Siddique, J John, J Mansi, M Harries, V Goh

S6 Accuracy of suspicious breast imaging—can we tell the patient?

S Seth, R Burgul, A Seth

S7 Measurement method of tumour volume changes during neoadjuvant chemotherapy affects ability to predict pathological response

S Waugh, N Muhammad Gowdh, C Purdie, A Evans, E Crowe, A Thompson, S Vinnicombe

S8 Diagnostic yield of CT IVU in haematuria screening

F. Arfeen, T. Campion, E. Goldstraw

S9 Percutaneous radiofrequency ablation of unresectable locally advanced pancreatic cancer: preliminary results

D’Onofrio M, Ciaravino V, Crosara S, De Robertis R, Pozzi Mucelli R

S10 Iodine maps from dual energy CT improve detection of metastases in staging examinations of melanoma patients

M. Uhrig, D. Simons, H. Schlemmer

S11Can contrast enhanced CT predict pelvic nodal status in malignant melanoma of the lower limb?

Kate Downey

S12 Current practice in the investigation for suspected Paraneoplastic Neurological Syndromes (PNS) and positive malignancy yield.

S Murdoch, AS Al-adhami, S Viswanathan

P1 Technical success and efficacy of Pulmonary Radiofrequency ablation: an analysis of 207 ablations

S Smith, P Jennings, D Bowers, R Soomal

P2 Lesion control and patient outcome: prospective analysis of radiofrequency abaltion in pulmonary colorectal cancer metastatic disease

S Smith, P Jennings, D Bowers, R Soomal

P3 Hepatocellular carcinoma in a post-TB patient: case of tropical infections and oncologic imaging challenges

TM Mutala, AO Odhiambo, N Harish

P4 Role of apparent diffusion coefficient (ADC) diffusion-weighted MRI for predicting extracapsular extension of prostate cancer

P. Pricolo, S. Alessi, P. Summers, E. Tagliabue, G. Petralia

P5 What a difference a decade makes; comparison of lung biopsies in Glasgow 2005 and 2015

M. Hall, M. Sproule, S. Sheridan

P6 Solid pseudopapillary tumour of pancreas: imaging features of a rare neoplasm

KY Thein, CH Tan, YL Thian, CM Ho

P7 MDCT - pathological correlation in colon adenocarcinoma staging: preliminary experience

S De Luca, C Carrera, V Blanchet, L Alarcón, E Eyheremnedy

P8 Image guided biopsy of thoracic masses and reduction of pneumothorax risk: 25 years experience

B K Choudhury, K Bujarbarua, G Barman

P9 Tumour heterogeneity analysis of 18F-FDG-PET for characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1

GJ Cook, E Lovat, M Siddique, V Goh, R Ferner, VS Warbey

P10 Impact of introduction of vacuum assisted excision (VAE) on screen detected high risk breast lesions

L Potti, B Kaye, A Beattie, K Dutton

P11 Can we reduce prevalent recall rate in breast screening?

AA Seth, F Constantinidis, H Dobson

P12 How to reduce prevalent recall rate? Identifying mammographic lesions with low Positive Predictive Value (PPV)

AA Seth (archana.seth@nhs.net), F Constantinidis, H Dobson

P13 Behaviour of untreated pulmonary thrombus in oncology patients diagnosed with incidental pulmonary embolism on CT

R. Bradley, G. Bozas, G. Avery, A. Stephens, A. Maraveyas

P14 A one-stop lymphoma biopsy service – is it possible?

S Bhuva, CA Johnson, M Subesinghe, N Taylor

P15 Changes in the new TNM classification for lung cancer (8^th edition, effective January 2017)

LE Quint, RM Reddy, GP Kalemkerian

P16 Cancer immunotherapy: a review of adequate imaging assessment

G González Zapico, E Gainza Jauregui, R Álvarez Francisco, S Ibáñez Alonso, I Tavera Bahillo, L Múgica Álvarez

P17 Succinate dehydrogenase mutations and their associated tumours

O Francies, R Wheeler, L Childs, A Adams, A Sahdev

P18 Initial experience in the usefulness of dual energy technique in the abdomen

SE De Luca, ME Casalini Vañek, MD Pascuzzi, T Gillanders, PM Ramos, EP Eyheremendy

P19 Recognising the serious complication of Richter’s transformation in CLL patients

C Stove, M Digby

P20 Body diffusion-weighted MRI in oncologic practice: truths, tricks and tips

M. Nazar, M. Wirtz, MD. Pascuzzi, F. Troncoso, F. Saguier, EP. Eyheremendy

P21 Methotrexate-induced leukoencephalopathy in paediatric ALL Patients

D.J. Quint, L. Dang, M. Carlson, S. Leber, F. Silverstein

P22 Pitfalls in oncology CT reporting. A pictorial review

R Rueben, S Viswanathan

P23 Imaging of perineural extension in head and neck tumours

B Nazir, TH Teo, JB Khoo

P24 MRI findings of molecular subtypes of breast cancer: a pictorial primer

K Sharma, N Gupta, B Mathew, T Jeyakumar, K Harkins

P25 When cancer can’t wait! A pictorial review of oncological emergencies

K Sharma, B Mathew, N Gupta, T Jeyakumar, S Joshua

P26 MRI of pancreatic neuroendocrine tumours: an approach to interpretation

D Christodoulou, S Gourtsoyianni, A Jacques, N Griffin, V Goh

P27 Gynaecological cancers in pregnancy: a review of imaging

CA Johnson, J Lee

P28 Suspected paraneoplastic neurological syndromes - review of published recommendations to date, with proposed guideline/flowchart

JA Goodfellow, AS Al-adhami, S Viswanathan

P29 Multi-parametric MRI of the pelvis for suspected local recurrence of prostate cancer after radical prostatectomy

R Bradley

P30 Utilisation of PI-RADS version 2 in multi-parametric MRI of the prostate; 12-months experience

R Bradley

P31 Radiological assessment of the post-chemotherapy liver

A Yong, S Jenkins, G Joseph

P32 Skeletal staging with MRI in breast cancer – what the radiologist needs to know

S Bhuva, K Partington

P33 Perineural spread of lympoma: an educational review of an unusual distribution of disease

CA Johnson, S Bhuva, M Subesinghe, N Taylor

P34 Visually isoattenuating pancreatic adenocarcinoma. Diagnostic imaging tools.

C Carrera, A Zanfardini, S De Luca, L Alarcón, V Blanchet, EP Eyheremendy

P35 Imaging of larynx cancer: when is CT, MRI or FDG PET/CT the best test?

K Cavanagh, E Lau